Delivery Order SPE2DB22D2005-SPE2DB26FJEP8
- Not listed
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors on October 28, 2025, with completion scheduled for October 29, 2025. The delivery order, which carries no set-aside designation, represents a competitive award under the company's broader pharmaceutical supply agreement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $15,944.25 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $4,839.72 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract is expected to be completed by September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,848.75 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger pharmaceutical supply framework with the federal...
- The Defense Logistics Agency awarded a $14,615.04 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on July 18, 2025, with completion scheduled for July 21, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $4,030.39 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. This is a firm fixed price, competitively awarded contract with a completion date of September 29, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was awarded through...
- The Defense Logistics Agency awarded a $35,903.76 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 ml pen injectors. This firm fixed-price contract, with an ultimate completion date of October 28, 2025, represents a pediatric formulation delivery supporting federal medical supply needs. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.44 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within...
- The Defense Logistics Agency awarded a $1,143.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by August 18, 2025. This delivery order was competitively awarded without...
- The Defense Logistics Agency awarded a $6,229.78 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 ml pen injections. This competitively awarded, non-set-aside contract features firm fixed pricing and an ultimate completion date of October 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJEP8Delivery Order
The Defense Logistics Agency awarded a $2,994.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors on October 27, 2025, with completion required by October 28, 2025. The award was made without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order is a child contract executed under AmerisourceBergen's broader pharmaceutical prime vendor agreement with DLA, which enables the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs worldwide. The delivery order is consistent with AmerisourceBergen's extensive portfolio of federal pharmaceutical deliveries, which encompass specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/27/25 |